The Effect of Oxygen Therapy on 6MWD in PAH and CTEPH Patients With Hypoxemia
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Treatment of O2 naïve patients with PAH will be included in this investigator-initiated trial
(IIT) to assess efficacy and safety of oxygen substitution. Nocturnal oxygen substitution
improved the 6MWD compared to placebo in one clinical trial in PAH patients. Due to the
positive results in the treatment of patients with PAH, the initiation of this
proof-of-concept study is justified.